| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/05/2003 | EP1061942B1 Topical composition containing human epidermal growth factor |
| 11/05/2003 | EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 11/05/2003 | EP1044007B1 Mannose for combating protein loss enteropathy |
| 11/05/2003 | EP1023069B1 Nicotine compositions and methods of formulation thereof |
| 11/05/2003 | EP1019047B1 Antithrombotic agents |
| 11/05/2003 | EP1009436B1 Acridine derivative for increasing the oral bioavailability of taxol |
| 11/05/2003 | EP1007034B1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 11/05/2003 | EP1003520B1 Hydroxy-prostaglandin derivatives for the treatment of erectile dysfunction |
| 11/05/2003 | EP1001792B1 Use of physiologically acceptable vanadium compounds, salts and complexes |
| 11/05/2003 | EP0994945B1 Smad-interacting polypeptides and their use |
| 11/05/2003 | EP0994713B1 USE OF A 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 11/05/2003 | EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 11/05/2003 | EP0975617B1 Inhibitors of cholesterol esterase |
| 11/05/2003 | EP0973527B1 Extended release formulations of clarithromycin |
| 11/05/2003 | EP0971930B1 Process for preparing single enantiomer narwedine |
| 11/05/2003 | EP0956854B1 Pharmaceutical composition comprising coenzyme q 10 |
| 11/05/2003 | EP0946566B1 Pro-drugs and counterparts of camptothecin, their application as medicines |
| 11/05/2003 | EP0921807B1 Hydrogenous medicament |
| 11/05/2003 | EP0902007B1 Chalcone derivatives and drugs containing the same |
| 11/05/2003 | EP0871432B1 Use of a composition containing polyether block copolymers |
| 11/05/2003 | EP0863991B1 Antigenic preparations |
| 11/05/2003 | EP0863747B1 Stimulation of hair follicles |
| 11/05/2003 | EP0839145B1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 11/05/2003 | EP0839039B1 Paroxetine controlled release compositions |
| 11/05/2003 | EP0814847B1 Methods and compositions for in-vivo detection of oral cancers and precancerous conditions |
| 11/05/2003 | EP0813413B1 Corticosteroid-containing foam |
| 11/05/2003 | EP0770064B1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 11/05/2003 | EP0715517B1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions |
| 11/05/2003 | EP0699073B1 xenogeneic transplantation |
| 11/05/2003 | EP0652874B1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 11/05/2003 | CN1454216A Antibodies to CCR5 |
| 11/05/2003 | CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides |
| 11/05/2003 | CN1454212A Intermediates in cephalosporing production |
| 11/05/2003 | CN1454211A Nitrogen containing heterobicycles as factor xa inhibitors |
| 11/05/2003 | CN1454210A 嘧啶衍生物 Pyrimidine derivatives |
| 11/05/2003 | CN1454209A 1-benzyl-4-[(5, 6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine |
| 11/05/2003 | CN1454205A Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 11/05/2003 | CN1454204A IL-8 receptor antagonists |
| 11/05/2003 | CN1454203A Substituted nitrated catechols their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 11/05/2003 | CN1454099A Dendrimer-photosensitizer complexes for medical applications |
| 11/05/2003 | CN1454094A Minari extract for preventing the induction and metast asis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks |
| 11/05/2003 | CN1454093A Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 11/05/2003 | CN1454091A Immunostimulatory nucleic acids |
| 11/05/2003 | CN1454090A Compositions and methods for improving cardiovascular function |
| 11/05/2003 | CN1454089A Diabetes remedies |
| 11/05/2003 | CN1454088A Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (HRT) |
| 11/05/2003 | CN1454087A The use of scopolamine salts |
| 11/05/2003 | CN1454086A High affinity small molecule C5A receptor modulators |
| 11/05/2003 | CN1454085A Clear aqueous anaesthetic composition |
| 11/05/2003 | CN1454084A Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 11/05/2003 | CN1454083A Selective androgen receptor modulators and methods for their identification design and use |
| 11/05/2003 | CN1454054A Treating smooth muscle hyperactivity with (R)-oxybutynin and (R)-desethyloxybutynin |
| 11/05/2003 | CN1453295A Medicinal polysaccharide component of spinulate hedgehog fungus, its prepn and medicinal composition |
| 11/05/2003 | CN1453290A Prepn of curcumol and oral medicine containing curcumol |
| 11/05/2003 | CN1453278A Omprazole compound and its prepn and application |
| 11/05/2003 | CN1453277A Meadowrueleaf corydalis general alkaloid and its prepn and application |
| 11/05/2003 | CN1453275A Novel indodyl oxazole compound and its prepn. and application |
| 11/05/2003 | CN1453274A Use and prepn process of flavone compound for treating urinary calculus and cholelithiasis |
| 11/05/2003 | CN1453258A Active component in Herba Siegesbeckia orientalis with antithrombus effect and its prepn and application |
| 11/05/2003 | CN1453010A Liniment for treating rheumarthritis and similar diseases and its prepn |
| 11/05/2003 | CN1452995A Externally applied paste for treating fracture and injured tendons |
| 11/05/2003 | CN1452994A Multifunctional paster |
| 11/05/2003 | CN1452983A Delayed-releasing compound diclofenac sodium prepn |
| 11/05/2003 | CN1452982A Mucosa administrated Ribavirin prepn for preventing & curing SARS and its prepn process |
| 11/05/2003 | CN1452981A Herpes virus treating medicine composition and its production process |
| 11/05/2003 | CN1452980A Pain-relieving and inflammation-diminishing medicine composition and its production process |
| 11/05/2003 | CN1452979A Medicine composition with anti-inflammatory effect and its production process |
| 11/05/2003 | CN1452978A Application of citrus paradisi Micf seed in preparing medicine for resisting SARS virus |
| 11/05/2003 | CN1452977A Clarithromycin injection |
| 11/05/2003 | CN1452976A Compound glucose injection with clindamycin and metronidazole |
| 11/05/2003 | CN1452975A Roxithromycin injection |
| 11/05/2003 | CN1452974A Globeflower powder for injection and its prepn |
| 11/05/2003 | CN1452973A Orally taken antioxidant and antilipemic medicine |
| 11/05/2003 | CN1452972A Plant extractive composition containing ginkgetin and its use |
| 11/05/2003 | CN1452971A Composition of gensenoside Rg1 and ferulic acid for preventing and treating cardiac and cerebral vascular diseases and diabetes and its application |
| 11/05/2003 | CN1452970A Anticancer application of 2-methoxy estradiol, Neomycin sulfate and their mixture |
| 11/05/2003 | CN1452969A Medical preparation for parenteral administration |
| 11/05/2003 | CN1452968A Novel drug-fast bacteria resisting medicine composition and its prepn and use |
| 11/05/2003 | CN1452967A Application of cepharanthine in preparing medicine for resisting SARS virus |
| 11/05/2003 | CN1452966A Compound Atenolol-Nifedipine slow releasing prepn |
| 11/05/2003 | CN1452965A Snuff |
| 11/05/2003 | CN1452964A Nasal spray agent |
| 11/05/2003 | CN1452963A Metronidazole prepn |
| 11/05/2003 | CN1452962A Medicine composition of maleic acid and Tegaserod and its prepn |
| 11/05/2003 | CN1452961A New use of theaflavin |
| 11/05/2003 | CN1452960A Garcinolic acid injection and its prepn |
| 11/05/2003 | CN1452959A Application of maltol in preventing and treating neuroretrogressive diseases |
| 11/05/2003 | CN1452958A Application of all transconfiguration vitamine A acid in preparing medicine for preventing and treating myocardial reconstution |
| 11/05/2003 | CN1452957A Ainfbutomon hydrochloride prepn |
| 11/05/2003 | CN1452956A Application of hypocrellin photosensitizer in pharmacy |
| 11/05/2003 | CN1452955A Eyesight improving prepn |
| 11/05/2003 | CN1126763C Process for continuous producing hydrolytically degraded optional selected substituted starch and equipment for carrying out the same process |
| 11/05/2003 | CN1126759C Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
| 11/05/2003 | CN1126755C Process for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide |
| 11/05/2003 | CN1126754C Process for preparing 3-cephem compound |
| 11/05/2003 | CN1126753C Pyrazolo (3,4-D) pyrimidines for anticonvulsive and antialiergic/antiasthmatic action |
| 11/05/2003 | CN1126752C Neuraminic acid compounds |
| 11/05/2003 | CN1126747C Novel 2-aminothiazol-fused 2-aminoindans and 2-aminotetralines and application thereof |
| 11/05/2003 | CN1126743C Substituted quinazoline derivatives |
| 11/05/2003 | CN1126741C Substituted benzamides compound |